Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil

被引：0
|
作者：
Yan-Ye Su
Chih-Yen Chien
Sheng-Dean Luo
Tai-Lin Huang
Wei-Che Lin
Fu-Min Fang
Tai-Jan Chiu
Yen-Hao Chen
Chi-Chih Lai
Cheng-Ming Hsu
Shau-Hsuan Li
机构：
[1] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Otolaryngology
[2] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Hematology
[3] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Oncology
[4] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Diagnostic Radiology
[5] Kaohsiung Chang Gung Memorial Hospital,Department of Radiation Oncology
来源：
World Journal of Surgical Oncology | / 14卷
关键词：
Head and neck cancer; Squamous cell carcinoma; Betel nut; Smoking; Induction chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
    Marin-Jimenez, Juan A.
    Oliva, Marc
    Martin, Paloma Peinado
    Cabezas-Camarero, Santiago
    Serrahima, Maria Plana
    Masedo, Gonzalo Vazquez
    Borbalas, Alicia Lozano
    Martin, Maria N. Cabrera
    Esteve, Anna
    Moreno, Maria C. Iglesias
    Altamis, Esther Vilajosana
    Hortiguela, Lorena Arribas
    Sanz, Miren Taberna
    Perez-Segura, Pedro
    Mesia, Ricard
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Feasibility and efficacy of chemoradiotherapy with concurrent split-dose cisplatin after induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for locally advanced head and neck cancer
    Yokota, Tomoya
    Shibata, Masayuki
    Hamauchi, Satoshi
    Shirasu, Hiromichi
    Onozawa, Yusuke
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Kawakami, Takeshi
    Furuta, Mitsuhiro
    Inoue, Hiroto
    Fushiki, Kunihiro
    Onitsuka, Tetsuro
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 13 (04) : 1 - 6
  • [33] Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin
    Thana Patimarattananan
    Arkom Nongnuch
    Poompis Pattaranutaporn
    Nattawut Unwanatham
    Chuleeporn Jiarpinitnun
    Nuttapong Ngamphaiboon
    Supportive Care in Cancer, 2021, 29 : 877 - 887
  • [34] Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin
    Patimarattananan, Thana
    Nongnuch, Arkom
    Pattaranutaporn, Poompis
    Unwanatham, Nattawut
    Jiarpinitnun, Chuleeporn
    Ngamphaiboon, Nuttapong
    SUPPORTIVE CARE IN CANCER, 2021, 29 (02) : 877 - 887
  • [35] Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck: A Phase I-II Study
    Perri, Francesco
    Muto, Paolo
    Argenone, Angela
    Ionna, Franco
    Longo, Francesco
    Fulciniti, Franco
    Sandomenico, Fabio
    Daponte, Antonio
    Caponigro, Francesco
    ONCOLOGY, 2013, 84 (04) : 251 - 254
  • [36] Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer
    Takacsi-Nagy, Zoltan
    Hitre, Erika
    Remenar, Eva
    Oberna, Ferenc
    Polgar, Csaba
    Major, Tibor
    Goedeny, Maria
    Fodor, Janos
    Kasler, Miklos
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (08) : 635 - 641
  • [37] Efficacy and Safety of Concomitant Chemoradiotherapy with Cisplatin and Docetaxel in Patients with Locally Advanced Squamous Cell Head and Neck Cancers
    Baykara, Meltem
    Buyukberber, Suleyman
    Ozturk, Banu
    Coskun, Ugur
    Unsal, Diclehan Kilic
    Demirci, Umut
    Dane, Faysal
    Kaplan, Muhammet Ali
    Bora, Huseyin
    Benekli, Mustafa
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (04) : 2557 - 2561
  • [38] Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer
    Huang, C-E.
    Lu, C-H.
    Chen, P-T.
    Chan, C-H. H.
    Chen, W-C.
    Wang, W-H.
    Wu, J-Y.
    Kuan, F-C.
    Lee, K-D.
    Chen, C-C.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (03) : 342 - 347
  • [39] Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer
    Hitt, Ricardo
    Mesia, Ricard
    Lozano, Alicia
    Iglesias Docampo, Lara
    Grau, Juan J.
    Taberna, Miren
    Rubio-Casadevall, Jordi
    Martinez-Trufero, Javier
    del Barco Morillo, Edel
    Garcia Giron, Carlos
    Vazquez Estevez, Sergio
    Cirauqui, Beatriz
    Jesus Cruz-Hernandez, Juan
    ORAL ONCOLOGY, 2022, 134
  • [40] Response to docetaxel and cisplatin induction chemotherapy of locally advanced head and neck squamous cell carcinoma: a multicenter, non-comparative, open-label interventional pilot study
    Noronha, V.
    Goswami, C.
    Patil, S.
    Joshi, A.
    Patil, V. M.
    Murthy, V.
    Arya, S.
    Juvekar, S.
    Goud, S.
    Prabhash, K.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 (09) : 833 - 842
12345